Viral arthritides

References

• Suhrbier A, Linn ML. Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses. Curr. Opin. Rheumatol.16(4), 374–379 (2004).
   PubMed Web of Science ®Google Scholar
• Kielian M, Chanel-Vos C, Liao M. Alphavirus entry and membrane fusion. Viruses2(4), 796–825 (2010).
   PubMed Web of Science ®Google Scholar
• Li L, Jose J, Xiang Y, Kuhn RJ, Rossmann MG. Structural changes of envelope proteins during alphavirus fusion. Nature468(7324), 705–708 (2010).
   PubMed Web of Science ®Google Scholar
• Voss JE, Vaney MC, Duquerroy S et al. Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature468(7324), 709–712 (2010).
   PubMed Web of Science ®Google Scholar
• Harley D, Sleigh A, Ritchie S. Ross River virus transmission, infection and disease: a cross-disciplinary review. Clin. Microbiol. Rev.14(4), 909–932 (2001).
   PubMed Web of Science ®Google Scholar
• Franssila R, Hedman K. Viral causes of arthritis. Best Pract. Res. Clin. Rheumatol.20(6), 1139–1157 (2006).
   PubMedGoogle Scholar
• Powers AM, Logue CH. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J. Gen Virol.88(9), 2363–2377 (2007).
   PubMed Web of Science ®Google Scholar
• Tsetsarkin KA, Vanlaningham DL, McGee CE, Higgs S. A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathogens3(12), e201 (2007).
   PubMed Web of Science ®Google Scholar
• Powers AM, Brault AC, Tesh RB, Weaver SC. Re-emergence of chikungunya and o’nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J. Gen. Virol.81(2), 471–479 (2000).
   PubMed Web of Science ®Google Scholar
• Gould EA, Higgs S. Impact of climate change and other factors on emerging arbovirus diseases. Trans. R. Soc. Trop. Med. Hyg.103(2), 109–121 (2009).
   PubMed Web of Science ®Google Scholar
• Rezza G, Nicoletti L, Angelini R et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet370(9602), 1840–1846 (2007).
   PubMed Web of Science ®Google Scholar
• Manimunda SP, Vijayachari P, Uppoor R et al. Clinical progression of chikungunya fever during acute and chronic arthritis stages and the changes in joint morphology as revealed by imaging. Trans. R. Soc. Trop. Med. Hyg.104(6), 392–399 (2010).
   PubMedGoogle Scholar
• Richardson M, Elliman D, Maguire H, Simpson J, Nicoll A. Evidence base of incubation periods, periods of infectiousness and exclusion policies for control of communicable diseases in schools and preschool. Pediatr. Infect Dis. J.20(4), 380–391 (2001).
   PubMedGoogle Scholar
• Tingle AJ, Allen M, Petty RE, Kettyls GD, Chantler JK. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation. Ann. Rhueum. Dis.45(2), 110–114 (1986).
   PubMed Web of Science ®Google Scholar
• Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science262(5130), 114–117 (1993).
   PubMed Web of Science ®Google Scholar
• Weigel-Kelley KA, Yoder MC, Srivasta A. α5β1 integrin as a cellular corecptor for human parvovirus B19: requirement of functional activation of β1 integrin for viral entry. Blood102(12), 3927–3933 (2003).
   PubMed Web of Science ®Google Scholar
• Munakata Y, Saito-Ito T, Kumura-Ishii K et al. Ku80 autoantigen as a cellular corecptor for parvovirus B19 infection. Blood106(10), 3449–3456 (2005).
   PubMedGoogle Scholar
• vondem Borne AE, Bos MJ, Joustra-Maas N, Tromp JF, Van Wijngaarden-du Bois R, Tetteroo PA. A murine monoclonal IgM antibody specific for blood group P antigen (globoside). Br. J. Haematol.63(1), 35–46 (1986).
   PubMedGoogle Scholar
• Enomoto-Iwamoto M, Iwamoto M, Nakashima K et al. Involvement of α5β1 integrin in matrix interactions and proliferation of chondrocytes. J. Bone Miner. Res.12(7), 1124–1132 (1997).
   PubMed Web of Science ®Google Scholar
• Hokynar K, Brunstein J, Söderlund-Venermo M et al. Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J. Gen. Virol.81(4), 1017–1025 (2000).
   PubMedGoogle Scholar
• Moore TL. Parvovirus-associated arthritis. Curr. Opin. Rheumatol.12(4), 289–294 (2000).
   PubMed Web of Science ®Google Scholar
• Young NS, Brown KE. Parvovirus B19. N. Engl. J. Med.350(6), 586–597 (2004).
   PubMed Web of Science ®Google Scholar
• Nocton JJ, Miller LC, Tucker LB, Schaller JG. Human parvovirus B19-associated arthritis in children. J. Pediatr.122(2), 186–190 (1993).
   PubMed Web of Science ®Google Scholar
• Woolf AD, Campion GV, Chishick A et al. Clinical manifestations of human parvovirus B19 in adults. Arch. Intern. Med.149(5), 1153–1156 (1989).
   PubMedGoogle Scholar
• Langgartner J, Audebert F, Schölmerich J, Glück T. Dengue virus infection transmitted by needle stick injury. J. Infect.44(4), 269–270 (2002).
   PubMedGoogle Scholar
• Adebajo AO. Dengue arthritis. Br. J. Rheumatol.35(9), 909–910 (1996).
   PubMedGoogle Scholar
• Nielsen DG. The relationship of interacting immunological components in dengue pathogenesis. Virology J.6, 211 (2009).
   PubMedGoogle Scholar
• Kularatne SA, Gihan MC, Weerasinghe SC, Gunasena S. Concurrent outbreaks of Chikungunya and Dengue fever in Kandy, Sri Lanka, 2006–07: a comparative analysis of clinical and laboratory features. Postgrad. Med. J.85(1005), 342–346 (2009).
   PubMedGoogle Scholar
• Lauer GM, Walker BD. Hepatitis C virus infection. N. Engl. J. Med.345(1), 41–52 (2001).
   PubMed Web of Science ®Google Scholar
• Mohammed RH, El Makhzangy HI, Garnal A et al. Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians. Clin. Rheumatol.29(12), 1373–1380 (2010).
   PubMed Web of Science ®Google Scholar
• Stefanova-Petrova DV, Tzvetanska AH, Naumova EJ et al. Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients. World J. Gastroenterol.13(48), 6518–6528 (2007).
   PubMedGoogle Scholar
• Cacoub P, Renou C, Rosenthal E et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine79(1), 47–56 (2000).
   PubMed Web of Science ®Google Scholar
• Olivieri I, Palazzi C, Padula A. Hepatitis C virus infection and arthritis. Rheum Dis. Clin. North Am.29(1), 111–122 (2003).
   PubMed Web of Science ®Google Scholar
• Rosner I, Rozenbaum M, Toubi E et al. The case for hepatitis C arthritis. Semin. Arthritis Rheum.33(6), 375–387 (2004).
   PubMedGoogle Scholar
• Reimold A. Viruses and arthritis: new challenges in diagnosis, therapy, and immunization. Am. J. Med. Sci.339(6), 549–556 (2010).
   PubMedGoogle Scholar
• Perl A. Mechanisms of viral pathogenesis in rheumatic disease. Ann. Rheum Dis.58(8), 454–461 (1999).
   PubMed Web of Science ®Google Scholar
• Zuckerman E, Yeshurin D, Rosner I. Management of hepatitis C virus-related arthritis. Bio Drugs.15(9), 573–584 (2001).
   Google Scholar
• Lee WM. Hepatitis B virus infection. N. Engl. J. Med.337(24), 1733–1745 (1997).
   PubMed Web of Science ®Google Scholar
• Vassilopoulos D, Calabrese LH. Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res. Ther.10(5), 215 (2008).
   PubMed Web of Science ®Google Scholar
• Wands JR, Mann E, Alpert E, Isselbacher KJ. The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes. J. Clin. Invest.55(5), 930–936 (1975).
   PubMed Web of Science ®Google Scholar
• Pease C, Keat A. Arthritis as the main or only symptom of hepatitis B infection. Postgrad. Med. J.61(716), 545–547 (1985).
   PubMedGoogle Scholar
• Walker UA, Tyndall A, Daikeler T. Rheumatic conditions in human immunodeficiency virus infection. Rheumatology (Oxford)47(7), 952–959 (2008).
   PubMed Web of Science ®Google Scholar
• Mody GM, Parke FA, Reveille JD. Articular manifestations of human immunodeficiency virus infection. Best Pract. Res. Clin. Rheumatol.17(2), 2265–2287 (2003).
   Google Scholar
• Reveille JD. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin. Arthritis Rheum.30(3), 147–166 (2000).
   PubMed Web of Science ®Google Scholar
• Saraux A, Taelman H, Blanche P et al. HIV infection as a risk factor for septic arthritis. Rheumatology36(3), 333–337 (1997).
   Google Scholar
• Patel N, Patel N, Espinoza LR. HIV infection and rheumatic diseases: the changing spectrum of clinical enigma. Rheum. Dis. Clin. N. Am.35(1), 139–161 (2009).
   PubMedGoogle Scholar
• Marquez J, Restrepo CS, Candia L, Berman A, Espinoza LR. Human immunodeficiency virus-associated rheumatic disorders in the HAART era. J. Rheumatol.31(4), 741–746 (2004).
   PubMedGoogle Scholar
• French MA. Immune reconstitution inflammatory syndrome: a reappraisal. Clin. Infect. Dis.48(1), 101–107 (2009).
   PubMed Web of Science ®Google Scholar
• Espinoza LR, Aguilar JL, Espinoza GG et al. HIV associated arthropathy: HIV antigen demonstration in the synovial membrane. J. Rheum.17(9), 1195–1201 (1990).
   PubMedGoogle Scholar
• Hughes RA, Macatonia SE, Rowe IF, Keat AC, Knight SC. The detection of human immunodeficiency virus DNA in dendritic cells from the joints of patients with aseptic arthritis. Br. J. Rheumatol.29(3), 166–170 (1990).
   PubMedGoogle Scholar
• Berman A, Reboredo G, Spindler A, Lasala ME, Lopez H, Espinoza LR. Rheumatic manifestations in populations at risk for HIV infection: the added effect of HIV. J. Rheum.18(10), 1564–1567 (1991).
   PubMed Web of Science ®Google Scholar
• Medina-Rodriguez F, Guzman C, Jara LJ. et al. Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors. J. Rheum.20(11), 1880–1884 (1993).
   PubMed Web of Science ®Google Scholar
• Dalton AD, Harcourt-Webater JN, Keat AC. Synovium in AIDS: a postmortem study. Br. Med. J.300(6734), 1239–1240 (1990).
   PubMedGoogle Scholar
• Berman A, Cahn P, Perez H et al. Human immunodeficiency virus infection associated arthritis: clinical characteristics. J. Rheum.26(5), 1158–1162 (1999).
   PubMedGoogle Scholar
• McCallum RM, Patel DD, Moore JO, Haynes BF. Arthritis syndromes associated with human T cell lymphotropic virus type I infection. Med. Clin. North Am.81(1), 261–276 (1997).
   PubMed Web of Science ®Google Scholar
• Hasunuma T, Sumida T, Nishioka K. Human T cell leukemia virus type-I and rheumatoid arthritis. Int. Rev. Immunol.17(5–6), 291–309 (1998).
   PubMedGoogle Scholar
• Sato K, Maruyama I, Maruyama Y et al. Arthritis in patients infected with human T lymphotropic virus type 1. Clinical and immunopathologic features. Arthritis Rheum.34(6), 714–721 (1991).
   PubMed Web of Science ®Google Scholar
• Kato T, Asahara H, Kurokawa MS et al. HTLV-1 env protein acts as a major antigen in patients with HTLV-1-associated arthropathy. Clin. Rheumatol.23(5), 400–409 (2004).
   PubMed Web of Science ®Google Scholar
• Motokawa S, Hasunama T, Tajima K et al. High prevalence of arthropathy in HTLV-1 carriers on a Japanese island. Ann. Rheum. Dis.55(3), 193–195 (1996).
   PubMed Web of Science ®Google Scholar
• Sebastian D, Nayiager S, York DY, Mody GM. Lack of association of human T-cell lymphotropic virus type 1 (HTLV-1) infection and rheumatoid arthritis in an endemic area. Clin. Rheum.22(1), 30–32 (2003).
   PubMed Web of Science ®Google Scholar
• Chhem RK, Wang S, Jaovisidha S et al. Imaging of fungal, viral, and parasitic musculoskeletal and spinal diseases. Radiol. Clin. North Am.39(2), 357–378 (2001).
   PubMedGoogle Scholar
• Yap G, Pok K, Lai Y et al. Evaluation of Chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks. PLoS Negl. Trop. Dis.4(7), e753 (2010).
   PubMedGoogle Scholar
• Carletti F, Bordi L, Chiappini R et al. Rapid detection and quantification of Chikungunya virus by a one-step reverse transcription polymerase chain reaction real-time assay. Am. J. Trop. Med. Hyg.77(3), 521–524 (2007).
   PubMed Web of Science ®Google Scholar
• Laurent P, Le Roux K, Grivard P et al. Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify Chikungunya virus. Clin. Chem.53(8), 1408–1414 (2007).
   PubMed Web of Science ®Google Scholar
• Best JM, O’Shea S, Tipples G et al. Interpretation of rubella serology in pregnancy – pitfalls and problems. Br. Med. J.325(7356), 147–148 (2002).
   PubMedGoogle Scholar
• Hudson P, Morgan-Capner P. Evaluation of 15 commercial enzyme immunoassays for the detection of rubella-specific IgM. Clin. Diagn. Virol.5(1), 21–26 (1996).
   PubMedGoogle Scholar
• Jensen IP, Vestergaard BF. Assessment of the specificity of a commercial human parvovirus B19 IgM assay. Clin. Diagn. Virol.7(3), 133–137 (1997).
   PubMedGoogle Scholar
• Mubareka S, Richards H, Gray M, Tipples GA. Evaluation of commercial rubella immunoglobulin G avidity assays. J. Clin. Microbiol.45(1), 231–233 (2007).
   PubMedGoogle Scholar
• Söderlund M, Brown CS, Cohen BJ, Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J. Infect Dis.171(3), 710–713 (1995).
   PubMed Web of Science ®Google Scholar
• Lai Y, Chung Y, Tan H et al. Cost-effective real-time reverse transcriptase PCR (RT-PCR) to screen for dengue virus followed by rapid single-tube multiplex RT-PCR for serotyping of the virus. J. Clin. Microbiol.45(3), 935–941 (2007).
   PubMed Web of Science ®Google Scholar
• Wang SM, Sekaran SD. Evaluation of commercial SD Dengue virus NS1 antigen capture enzyme-linked immunosorbent assay kit for early diagnosis of dengue virus infection. J. Clin. Microbiol.48(8), 2793–2797 (2010).
   PubMed Web of Science ®Google Scholar
• Tricou V, Vu HT, Quynh NV et al. Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses. BMC Infect. Dis.10, 142 (2010).
   PubMed Web of Science ®Google Scholar
• Lima MR, Nogueira RM, Schatzmar HG, dos Santos FB. Comparison of three commercially available dengue NS1 antigen capture assays for acute diagnosis of dengue in Brazil. PLoS Negl. Trop. Dis.4(7), e738 (2010).
   PubMedGoogle Scholar
• Naze F, Le Roux K, Schuffenecker I et al. Simultaneous detection and quantitation of Chikungunya, dengue and West Nile viruses by multiplex RT-PCR assays and dengue virus typing using high resolution melting. J. Virol. Methods162(1–2), 1–7 (2009).
   PubMed Web of Science ®Google Scholar
• Chevaliez S, Pawlotsky J. Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int. J. Med. Sci.3(2), 35–40 (2006).
   PubMedGoogle Scholar
• Bombardieri M, Alessandri C, Labbadia G et al. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res. Ther.6(2), R137–R141 (2004).
   PubMed Web of Science ®Google Scholar
• Lim M, Sheen D, Lee YJ, Mun YR, Park M, Shim S. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. J. Rheum.36(4), 712–716 (2009).
   PubMedGoogle Scholar
• Guennoc X, Narbonne V, Jousse-Joulin S et al. Is screening for hepatitis B and hepatitis C useful in patients with recent-onset polyarthritis? The ESPOIR Cohort Study. J. Rheum.36(7), 1407–1413 (2009).
   PubMedGoogle Scholar
• Kim D, Kim T. Is screening for hepatitis necessary in diagnostic evaluation of rheumatoid arthritis in South Korea? J. Rheum.37(3), 674–675 (2010).
   PubMedGoogle Scholar
• Besson G, Kazanji M. One-step, multiplex, real-time PCR assay with molecular beacon probes for simultaneous detection, differentiation, and quantification of human T-cell leukaemia virus types 1, 2, and 3. J. Clin. Microbiol.47(4), 1129–1135 (2009).
   PubMedGoogle Scholar
• Moens B, López G, Adaui V et al. Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1,2 and 3 proviral load determination. J. Clin. Microbiol.47(11), 3682–3691 (2009).
   PubMedGoogle Scholar
• Palazzi C, Olivieri I, Cacciatore P, Pennese E, D’Amico E. Management of hepatitis C virus-related arthritis. Expert Opin. Pharmacotherapy6(1), 27–34 (2005).
   PubMed Web of Science ®Google Scholar
• Cansu DU, Kalifoglu T, Korkmaz C. Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis. J. Rheum.35(3), 421–424 (2008).
   PubMed Web of Science ®Google Scholar
• Iannuzzella F, Vaglio A, Garini G. Management of hepatitis C virus-related mixed cryoglobulinemia. Am. J. Med.123(5), 400–408 (2010).
   PubMedGoogle Scholar
• Guillevin L, Mahr A, Callard P et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore)84(5), 313–322 (2005).
   PubMed Web of Science ®Google Scholar
• Mok MY, Ng WL, Yuen MF, Wong RW, Lau CS. Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis. Clin. Exp. Rheumatol.18(3), 363–368 (2000).
   PubMed Web of Science ®Google Scholar
• Chung S, Kim JK, Park M, Park Y, Lee S. Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumour necrosis factor-α therapy. J. Rheum.36(11), 2416–2420 (2009).
   PubMed Web of Science ®Google Scholar
• Dai M, Lu J, Chen Y, Perng C, Chao T. Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients. Cancer92(11), 2927–2932 (2001).
   PubMedGoogle Scholar
• Hagiyama H, Kubota T, Komano Y, Kurosaki M, Watanabe M, Miyasaka N. Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis. Clin. Exp. Rheumatol.22(3), 375–376 (2004).
   PubMed Web of Science ®Google Scholar
• Kuwabara H, Fukuda A, Tsuda Y, Shibayama Y. Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis. Clin. Rheumatol. DOI: 10.1007/s10067-010-1438-y (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Katz LH, Fraser A, Gafter-Gvill A, Lebovici L, Tur-Kaspa R. Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis. J. Viral Hepat.15(2), 89–102 (2008).
   PubMed Web of Science ®Google Scholar
• Loomba R, Rowley A, Wesley R et al. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann. Intern. Med.148(7), 519–528 (2008).
   PubMed Web of Science ®Google Scholar
• Vassilopoulos D, Apostolopoulou A, Hadziyannis E et al. Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection. Ann. Rheum Dis.69(7), 1352–1355 (2010).
   PubMed Web of Science ®Google Scholar
• Ferri C, Govoni M, Calabrese L. The A, B, Cs of viral hepatitis in the biologic era. Curr. Opin. Rheumatol.22(4), 443–450 (2010).
   PubMed Web of Science ®Google Scholar
• Bourinbaiar AS, Lee-Huang S. The non-steroidal anti-inflammatory drug, indomethacin, as an inhibitor of HIV replication. FEBS Lett.360(1), 85–88 (1995).
   PubMedGoogle Scholar
• Ornstein MH, Sperber K. The anti-inflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis. Arthritis Rheum.39(1), 157–161 (1996).
   PubMedGoogle Scholar
• Masson C, Chennebault JM, Leclech C. Is HIV infection contraindication to the use of methotrexate in psoriatic arthritis? J. Rheum.22(11), 2191 (1995).
   PubMedGoogle Scholar
• Duvic M, Crane MM, Conant M, Mahoney SE, Reveille JD, Lehrman SN. Zidovudine improves psoriasis in human immunodeficiency virus-positive males. Arch. Dermatol.130(4), 447–451 (1994).
   PubMedGoogle Scholar
• Calabrese LH, Kirchner E, Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: Emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin. Arthritis Rheum.35(3), 166–174 (2005).
   PubMed Web of Science ®Google Scholar